Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience-Reference-Cited by-同舟云学术

Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience

Published:2014-05-08 Issue:1 Volume:20 Page:53-58
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Yoshitake Tadamasa,Nakamura Katsumasa,Shioyama Yoshiyuki,Sasaki Tomonari,Ohga Saiji,Shinoto Makoto,Terashima Kotaro,Asai Kaori,Matsumoto Keiji,Matsuo Yoshio,Baba Shingo,Honda Hiroshi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-014-0698-y.pdf

Reference19 articles.

1. Onishi H, Araki T (2013) Stereotactic body radiation therapy for stage I non-small-cell lung cancer: a historical overview of clinical studies. Jpn J Clin Oncol 43:345–350

2. Inoue T, Shimizu S, Onimaru R et al (2009) Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination. Int J Radiat Oncol Biol Phys 75:683–687

3. Takeda A, Kunieda E, Sanuki N et al (2012) Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer. Lung Cancer 77:77–82

4. Verstegen NE, Lagerwaard FJ, Haasbeek CJ et al (2011) Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. Radiother Oncol 101:250–254

5. Sakanaka K, Matsuo Y, Nagata Y et al (2013) Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation. Int J Clin Oncol. doi: 10.1007/s10147-013-0637-3

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Clinical Factors and Radiomics Can Predict Local Recurrence and Metastasis After Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer;Anticancer Research;2023-11

2. Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof;Radiation Oncology;2023-03-08

3. Stereotactic body radiation therapy for empirically treated hypermetabolic lung lesions: a single-institutional experience identifying the Charlson score as a key prognostic factor;Translational Lung Cancer Research;2020-10

4. Chest Wall Toxicity after Stereotactic Radiation in Early Lung Cancer: A Systematic Review;Current Oncology;2020-08-01

5. Survival After Stereotactic Body Radiation Therapy for Clinically Diagnosed or Biopsy-Proven Early-Stage NSCLC: A Systematic Review and Meta-Analysis;Journal of Thoracic Oncology;2019-04